Sale!

Anti NMDA Receptor Anti-Glutamate Antibody CSF Test Cost

Original price was: 1,630 د.إ.Current price is: 1,470 د.إ.

-10%

The Anti NMDA Receptor Anti-Glutamate Antibody CSF Test is a specialized diagnostic procedure aimed at detecting antibodies against the NMDA (N-methyl-D-aspartate) receptor in the cerebrospinal fluid (CSF). These antibodies are indicative of autoimmune encephalitis, a serious condition where the body’s immune system mistakenly attacks healthy brain cells, leading to inflammation and a range of neurological symptoms. This test plays a crucial role in diagnosing the condition, guiding treatment plans, and monitoring disease progression or response to therapy.

Performed at DNA Labs UAE, the test requires a sample of cerebrospinal fluid, which is collected through a lumbar puncture procedure. The laboratory employs advanced immunological techniques to identify the presence of anti-glutamate receptor antibodies, which are hallmark indicators of anti-NMDA receptor encephalitis.

The cost of the Anti NMDA Receptor Anti-Glutamate Antibody CSF Test at DNA Labs UAE is 1470 AED. Given the complexity of the test and the specialized expertise required to interpret the results, it represents a critical investment in accurately diagnosing and managing conditions associated with anti-NMDA receptor antibodies. Patients undergoing this test at DNA Labs UAE can expect state-of-the-art diagnostic facilities and professional care, ensuring reliable and timely results.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

ANTI NMDA RECEPTOR ANTI-GLUTAMATE ANTIBODY CSF Test

Test Name: ANTI NMDA RECEPTOR ANTI-GLUTAMATE ANTIBODY CSF Test

Components: Cell based assay, IFA

Price: 1470.0 AED

Sample Condition: 1 mL (0.5 mL min) CSF in a sterile screw capped container. Ship refrigerated or frozen.

Report Delivery: SampleTue / Fri by 9 am; Report Same day

Method: Cell based assay, IFA

Test type: Disorders of Nervous System

Doctor: Neurologist

Test Department: IMMUNOPATHOLOGY

Pre Test Information

Test Details:

The anti-NMDA receptor/anti-glutamate antibody CSF test is a diagnostic test used to detect the presence of antibodies against the NMDA receptor or glutamate in the cerebrospinal fluid (CSF). The NMDA receptor is a type of receptor found in the brain that plays a crucial role in the regulation of synaptic plasticity and memory formation. However, in certain conditions, such as autoimmune encephalitis, antibodies can mistakenly attack and target the NMDA receptor, leading to neurological symptoms.

The test involves collecting a sample of CSF through a lumbar puncture, which is a procedure where a needle is inserted into the lower back to withdraw a small amount of CSF. The CSF sample is then sent to a laboratory for analysis. In the laboratory, the CSF sample is tested for the presence of antibodies against the NMDA receptor or glutamate using various techniques, such as enzyme-linked immunosorbent assay (ELISA) or immunofluorescence.

If the test is positive, it indicates that there are antibodies present in the CSF that are targeting the NMDA receptor or glutamate. The anti-NMDA receptor/anti-glutamate antibody CSF test is primarily used in the diagnosis of autoimmune encephalitis, a condition characterized by inflammation of the brain due to the presence of autoantibodies. This test helps differentiate autoimmune encephalitis from other neurological conditions with similar symptoms.

It is important to note that the test results should be interpreted in conjunction with the patient’s clinical symptoms and other diagnostic tests to make an accurate diagnosis. Treatment for autoimmune encephalitis typically involves immunosuppressive therapy to reduce the autoimmune response and manage symptoms.

Test Name ANTI NMDA RECEPTOR ANTI-GLUTAMATE ANTIBODY CSF Test
Components
Price 1470.0 AED
Sample Condition 1 mL (0.5 mL min) CSF in a sterile screw capped container. Ship refrigerated or frozen.
Report Delivery SampleTue / Fri by 9 am; Report Same day
Method Cell based assay, IFA
Test type Disorders of Nervous System
Doctor Neurologist
Test Department: IMMUNOPATHOLOGY
Pre Test Information
Test Details

The anti-NMDA receptor/anti-glutamate antibody CSF test is a diagnostic test used to detect the presence of antibodies against the NMDA receptor or glutamate in the cerebrospinal fluid (CSF).

The NMDA receptor is a type of receptor found in the brain that plays a crucial role in the regulation of synaptic plasticity and memory formation. However, in certain conditions, such as autoimmune encephalitis, antibodies can mistakenly attack and target the NMDA receptor, leading to neurological symptoms.

The test involves collecting a sample of CSF through a lumbar puncture, which is a procedure where a needle is inserted into the lower back to withdraw a small amount of CSF. The CSF sample is then sent to a laboratory for analysis.

In the laboratory, the CSF sample is tested for the presence of antibodies against the NMDA receptor or glutamate using various techniques, such as enzyme-linked immunosorbent assay (ELISA) or immunofluorescence. If the test is positive, it indicates that there are antibodies present in the CSF that are targeting the NMDA receptor or glutamate.

The anti-NMDA receptor/anti-glutamate antibody CSF test is primarily used in the diagnosis of autoimmune encephalitis, a condition characterized by inflammation of the brain due to the presence of autoantibodies. This test helps differentiate autoimmune encephalitis from other neurological conditions with similar symptoms.

It is important to note that the test results should be interpreted in conjunction with the patient’s clinical symptoms and other diagnostic tests to make an accurate diagnosis. Treatment for autoimmune encephalitis typically involves immunosuppressive therapy to reduce the autoimmune response and manage symptoms.